Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model
Open Access
- 10 October 2012
- journal article
- Published by Springer Science and Business Media LLC in Cardiovascular Ultrasound
- Vol. 10 (1), 40
- https://doi.org/10.1186/1476-7120-10-40
Abstract
In the clinical setting, the early detection of myocardial injury induced by doxorubicin (DXR) is still considered a challenge. To assess whether ultrasonic tissue characterization (UTC) can identify early DXR-related myocardial lesions and their correlation with collagen myocardial percentages, we studied 60 rats at basal status and prospectively after 2mg/Kg/week DXR endovenous infusion. Echocardiographic examinations were conducted at baseline and at 8,10,12,14 and 16 mg/Kg DXR cumulative dose. The left ventricle ejection fraction (LVEF), shortening fraction (SF), and the UTC indices: corrected coefficient of integrated backscatter (IBS) (tissue IBS intensity/ phantom IBS intensity) (CC-IBS) and the cyclic variation magnitude of this intensity curve (MCV) were measured. The variation of each parameter of study through DXR dose was expressed by the average and standard error at specific DXR dosages and those at baseline. The collagen percent (%) was calculated in six control group animals and 24 DXR group animals. CC-IBS increased (1.29±0.27 x 1.1±0.26-basal; p=0.005) and MCV decreased (9.1± 2.8 x 11.02±2.6-basal; p=0.006) from 8 mg/Kg to 16mg/Kg DXR. LVEF presented only a slight but significant decrease (80.4±6.9% x 85.3±6.9%-basal, p=0.005) from 8 mg/Kg to 16 mg/Kg DXR. CC-IBS was 72.2% sensitive and 83.3% specific to detect collagen deposition of 4.24%(AUC=0.76). LVEF was not accurate to detect initial collagen deposition (AUC=0.54). In conclusion: UTC was able to early identify the DXR myocardial lesion when compared to LVEF, showing good accuracy to detect the initial collagen deposition in this experimental animal model.Keywords
This publication has 29 references indexed in Scilit:
- Identification of Anthracycline Cardiotoxicity: Left Ventricular Ejection Fraction Is Not EnoughJournal of the American Society of Echocardiography, 2008
- Strain Rate Imaging Detects Early Cardiac Effects of Pegylated Liposomal Doxorubicin as Adjuvant Therapy in Elderly Patients with Breast CancerJournal of the American Society of Echocardiography, 2008
- Serial Assessment of Myocardial Properties Using Cyclic Variation of Integrated Backscatter in an Adriamycin-Induced Cardiomyopathy Rat ModelYonsei Medical Journal, 2005
- Ultrasonic tissue characterization for patients with Chagas' diseaseJournal of the American Society of Echocardiography, 2004
- Ultrasonic analysis of anthracycline-induced myocardial damage using cyclic variation of integrated backscatterJournal of the American Society of Echocardiography, 2003
- Myocardial ultrasonic tissue characterization in patients with different types of left ventricular hypertrophy: A videodensitometric approachJournal of the American Society of Echocardiography, 1997
- Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: Value in noninvasive assessment of myocardial fibrosisAmerican Heart Journal, 1996
- The variation of integrated backscatter in human hearts in differing ultrasonic transthoracic viewsJournal of the American Society of Echocardiography, 1995
- Detection of cardiomyopathic changes induced by doxorubicin based on quantitative analysis of ultrasonic backscatterThe American Journal of Cardiology, 1981
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976